Telemedicine Abortion in Primary Care: An Exploration of Patient Experiences
- PMID: 38253506
- PMCID: PMC11233084
- DOI: 10.1370/afm.3058
Telemedicine Abortion in Primary Care: An Exploration of Patient Experiences
Abstract
Purpose: The purpose of the study was to explore patients' experiences and perspectives obtaining telemedicine medication abortion (TeleMAB) through their primary care health system.
Methods: We conducted in-depth telephone interviews with 14 English-, Spanish-, and/or Portuguese-speaking patients who received a TeleMAB between July 2020 and December 2021, within a large primary care safety-net community health system in Massachusetts. We created and piloted a semistructured interview guide informed by patient-clinician communication frameworks and prior studies on patient experiences with TeleMAB. We analyzed data using reflexive thematic analysis and summarized main themes.
Results: Overall, participants found TeleMAB services in their primary care health system acceptable, positive, and easy. Participants discussed how TeleMAB supported their ability to exercise control, autonomy, and flexibility, and decreased barriers experienced with in-clinic care. Many participants perceived their primary care health system as the place to go for any pregnancy-related health care need, including abortion. They valued receiving abortion care from their established health care team within the context of ongoing social and medical concerns.
Conclusions: Patients find TeleMAB from their primary care health system acceptable and beneficial. Primary care settings can integrate TeleMAB services to decrease care silos, normalize abortion as a part of comprehensive primary care, and improve access through remote care offerings. TeleMAB supports patients' access and autonomy, with the potential to benefit many people of reproductive age.
Keywords: abortion; acceptability; access; normalize; patient experience; primary care; telemedicine.
© 2024 Annals of Family Medicine, Inc.
Similar articles
-
Telehealth Medication Abortion in Primary Care: A Comparison to Usual in-Clinic Care.J Am Board Fam Med. 2024 Mar-Apr;37(2):295-302. doi: 10.3122/jabfm.2023.230178R1. J Am Board Fam Med. 2024. PMID: 38740468
-
Perceptions and experiences with two no-test direct-to-patient telehealth medication abortion regimens in the USA: an exploratory study with mifepristone and misoprostol and misoprostol-only regimens.BMJ Public Health. 2024 Oct 26;2(2):e000808. doi: 10.1136/bmjph-2023-000808. eCollection 2024 Dec. BMJ Public Health. 2024. PMID: 40018617 Free PMC article.
-
"It was close enough, but it wasn't close enough": A qualitative exploration of the impact of direct-to-patient telemedicine abortion on access to abortion care.Contraception. 2021 Jul;104(1):67-72. doi: 10.1016/j.contraception.2021.04.028. Epub 2021 Apr 30. Contraception. 2021. PMID: 33933421
-
Medical abortion offered in pharmacy versus clinic-based settings.Cochrane Database Syst Rev. 2021 Jun 11;6(6):CD013566. doi: 10.1002/14651858.CD013566.pub2. Cochrane Database Syst Rev. 2021. PMID: 34114643 Free PMC article.
-
The Provision of Abortion Care via Telehealth in the United States: A Rapid Review.J Midwifery Womens Health. 2023 Nov-Dec;68(6):744-758. doi: 10.1111/jmwh.13586. Epub 2023 Dec 9. J Midwifery Womens Health. 2023. PMID: 38069588 Review.
References
-
- Stevenson AJ, Root L, Menken J.. The maternal mortality consequences of losing abortion access. Published 2022. 10.31235/osf.io/7g29k - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical